Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4124 Target Snapshot

Histamine H3 receptor · SINGLE PROTEIN · Rattus norvegicus

1,870Compounds
276Assays
3Approved Drugs
2,438.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9QYN8. Use UniProt Q9QYN8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9QYN8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histamine H3 receptor as ChEMBL target CHEMBL4124, mapped to UniProt Q9QYN8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histamine H3 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL4124
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9QYN8
Histamine H3 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histamine H3 receptor is the right protein anchor across sources, using UniProt Q9QYN8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistamine H3 receptor
UniProt AccessionQ9QYN8
Component TypeProtein
Sequence Length445 aa

Histamine H3 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histamine H3 receptor, mapped to UniProt Q9QYN8. Sequence length is 445 aa.

Mapped IDQ9QYN8
Review nameHistamine H3 receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

3
Approved
16
Phase II
Assay Mix

Activity Type Distribution

IC5013.0
KI2,347.0
EC5042.0
KD36.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2386729 10.7 Ki 0.02 Preclinical
CHEMBL2386727 10.49 Ki 0.032 Preclinical
CHEMBL270011 10.35 Ki 0.04467 Preclinical
CHEMBL2386728 10.3 Ki 0.05 Preclinical
CHEMBL255962 10.3 Ki 0.05 Preclinical
CHEMBL408934 10.17 Ki 0.06761 Preclinical
CHEMBL401954 10.11 Ki 0.07762 Preclinical
CHEMBL1085337 10.1 Ki 0.08 Preclinical
CHEMBL368398 10.1 Ki 0.07943 Preclinical
CHEMBL402640 10.0 Ki 0.1 Preclinical
Distribution

pChEMBL Value Distribution

8
5.0
23
5.5
87
6.0
227
6.5
357
7.0
518
7.5
489
8.0
322
8.5
182
9.0
42
9.5
pChEMBL
Approved Drugs

Approved Drugs

PITOLISANT
CHEMBL462605
Approved 2016
CIPROFLOXACIN
CHEMBL8
Approved 1987
HISTAMINE
CHEMBL90
Approved 1939
Assay Landscape

Assay Landscape

276
Total Assays
1,638
Tested Compounds
2
Assay Types
Binding — 178 assays, 1,638 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 56 459 7.9
cell-based format 37 326 8.0
cell membrane format 25 324 7.8
assay format 24 311 8.0
subcellular format 16 158 7.9
tissue-based format 16 60 7.9
organism-based format 4 0
Functional — 98 assays, 288 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 35 24 7.6
subcellular format 28 187 7.8
tissue-based format 21 31 7.3
cell-based format 12 41 8.2
cell membrane format 2 5 8.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine